Silver Set to Outpe...
Health Care: Drugs
Pfizer Inc (PFE: NYSE)
$20.98 -0.16 | -0.73%
02/10/12 - 10:30 AM ET
4.56M / 43.53M
Vol / Avg. Vol:21.00 / 21.14
Open / Prev. Close:20.90 - 21.06
Today's Range:16.63 - 22.17
52 Wk Range:-2.31%
Performance YTD:TheStreet Rating:
Portfolios with PFE
- Portfolio NameUser Type
- UserMy Portfolio
- User2012 BP Stocks
- Contributor10 Top Dividend Stocks to O...
- Userdennis all star
- Contributor2 Dividend Stocks Offering ...
- UserNick's Portfolio
- UserBig plays
- ContributorHighest-Yielding Drug Stocks
- UserDividends
- ContributorNew Year's Resolution Stocks
Latest PFE Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Balancing Act (Final) 02.08.12 | 07:02 pm
- 'Mad Money Lightning Round': Get Some Covidien 02.08.12 | 07:02 pm
- Buy Dividend Stocks as Market 'Smells Like Speculation' 02.08.12 | 06:02 am
- Corporate Profits Aren't What They Seem 02.06.12 | 05:02 pm
- Boeing, Pfizer, Travelers: Dow Movers 02.06.12 | 05:02 pm
- They Just Don't Get Merck!
02.05.12 | 09:02 am - Merck's Lower Tax Rate 02.04.12 | 09:02 am
- 3 Stocks I Saw on TV, February 3 02.03.12 | 07:02 am
- Disney, Pfizer: Dow Movers 02.02.12 | 04:02 pm
- Merck's Risky Cost Cutting Move 02.02.12 | 12:02 pm
Press Releases for PFE
- Branham Law Group Investigates Pfizer For Qualitest Packaging Error Recall - Business Wire 02.09.12 | 02:02 pm
- Siemens Forms New Companion Diagnostics Partnerships With ViiV Healthcare And Tocagen - PR Newswire 02.07.12 | 11:02 am
- St. Louis-based Carey, Danis & Lowe Announces Suit Against The Maker Of Zoloft - Business Wire 02.06.12 | 03:02 pm
- Keller Rohrback L.L.P. Announces Investigation Of Pfizer, Inc. Regarding The Lo/Ovral®-28 And Norgestrel Birth Control Pill Recall - Business Wire 02.03.12 | 06:02 pm
- Chief Medical Officer Dr. Freda Lewis-Hall Addresses Company's Voluntary Recall Of Contraceptive Products - Business Wire 02.01.12 | 04:02 pm
- Pfizer Reports Fourth-Quarter And Full-Year 2011 Results; Updates 2012 Financial Guidance - Business Wire 01.31.12 | 07:01 am
- U.S. Food And Drug Administration Approves Pfizer’s INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) - Business Wire 01.27.12 | 01:01 pm
- Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia - Business Wire 01.27.12 | 08:01 am
- Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer's Care - PR Newswire 01.26.12 | 08:01 am
- Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care - Business Wire 01.26.12 | 08:01 am
Partner Headlines for PFE
- Forget Big Pharma, It's Time For A Biotech ETF - ETF News And Commentary - Zacks 02.09.12 | 10:02 am
- The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer - Press Releases - Zacks 02.09.12 | 09:02 am
- The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca - Press Releases - Zacks 02.07.12 | 09:02 am
- Dr. Reddy's Going Strong - Analyst Blog - Zacks 02.06.12 | 10:02 am
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
- Stock Market News for February 1, 2012 - Market News - Zacks 02.01.12 | 10:02 am
- The Zacks Analyst Blog Highlights: Pfizer, Eli Lilly, Archer Daniels Midland, RadioShack and Sprint - Press Releases - Zacks 02.01.12 | 09:02 am
- The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche - Press Releases - Zacks 02.01.12 | 09:02 am
- What Is A Moat? - Seeking Alpha 02.01.12 | 08:02 am
- Earnings Roll Out as EU Makes Progress - Analyst Blog - Zacks 01.31.12 | 10:01 am
